Novartis unit Sandoz sues to revoke Bayer’s patents for blood thinner Xarelto

Ashurst 2021-11-23 3:30 pm By Christine Caulfield | Melbourne

Please login to bookmark

Generic drug maker Sandoz AG has filed proceedings seeking the revocation of two patents registered in Australia by German pharmaceutical giant Bayer covering its top-selling blood clot drug Xarelto.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au